Navamedic ASA completes acquisition of Impolin AB and issues consideration shares
yahoo.com
finance
2022-06-01 14:50:00

OSLO, Norway, June 1, 2022 /PRNewswire/ -- Navamedic ASA ("Navamedic" or the "Company") (OSE: NAVA) today announces that it has completed the acquisition of Impolin AB, as announced by the Company on 5 May 2022.

As partial settlement of the purchase price for the acquisition, the board of directors of Navamedic has today, on 1 June 2022, resolved to increase the Company's share capital with NOK 597,266.58 by issuance of 807,117 new shares in the Company to Agnvicen AB, being the seller of Impolin AB, each with a nominal value of NOK 0.
